367 related articles for article (PubMed ID: 19390205)
1. Impact of obesity on IgA nephropathy: comparative ultrastructural study between obese and non-obese patients.
Tanaka M; Yamada S; Iwasaki Y; Sugishita T; Yonemoto S; Tsukamoto T; Fukui S; Takasu K; Muso E
Nephron Clin Pract; 2009; 112(2):c71-8. PubMed ID: 19390205
[TBL] [Abstract][Full Text] [Related]
2. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
3. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological influence of obesity in IgA nephropathy: comparative study of 74 patients.
Tanaka M; Tsujii T; Komiya T; Iwasaki Y; Sugishita T; Yonemoto S; Tsukamoto T; Fukui S; Takasu A; Muso E
Contrib Nephrol; 2007; 157():90-3. PubMed ID: 17495442
[TBL] [Abstract][Full Text] [Related]
5. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
7. Obesity-related glomerulopathy in China: a case series of 90 patients.
Chen HM; Li SJ; Chen HP; Wang QW; Li LS; Liu ZH
Am J Kidney Dis; 2008 Jul; 52(1):58-65. PubMed ID: 18423814
[TBL] [Abstract][Full Text] [Related]
8. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.
Kennoki T; Ishida H; Yamaguchi Y; Tanabe K
Transplantation; 2009 Oct; 88(7):935-41. PubMed ID: 19935466
[TBL] [Abstract][Full Text] [Related]
9. Association of angiotensin-converting enzyme gene polymorphism and renal pathology in Japanese children with IgA nephropathy.
Asano T; Tatsuma N; Yoshida J; Ohashi R; Ambo K; Tsuchiya M; Murakami M; Yamanaka N; Honda M; Yamamoto M
Clin Nephrol; 1999 Jun; 51(6):335-40. PubMed ID: 10404693
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[TBL] [Abstract][Full Text] [Related]
11. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
Ikee R; Kobayashi S; Saigusa T; Namikoshi T; Yamada M; Hemmi N; Imakiire T; Kikuchi Y; Suzuki S; Miura S
Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
[TBL] [Abstract][Full Text] [Related]
12. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
[TBL] [Abstract][Full Text] [Related]
13. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[TBL] [Abstract][Full Text] [Related]
14. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B
Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747
[TBL] [Abstract][Full Text] [Related]
15. Early histological changes in the kidney of people with morbid obesity.
Goumenos DS; Kawar B; El Nahas M; Conti S; Wagner B; Spyropoulos C; Vlachojannis JG; Benigni A; Kalfarentzos F
Nephrol Dial Transplant; 2009 Dec; 24(12):3732-8. PubMed ID: 19596742
[TBL] [Abstract][Full Text] [Related]
16. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
Linossier MT; Palle S; Berthoux F
Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
[TBL] [Abstract][Full Text] [Related]
17. Applicability of steroid therapy in 275 adult patients with IgA nephropathy determined using a histological scoring system and degree of proteinuria.
Suzuki S; Joh K
Clin Exp Nephrol; 2004 Jun; 8(2):109-16. PubMed ID: 15235927
[TBL] [Abstract][Full Text] [Related]
18. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
Jeong HJ; Park SK; Cho YM; Kim MS; Kim YS; Choi J; Kim SI; Lim BJ
Hum Pathol; 2008 Oct; 39(10):1511-8. PubMed ID: 18620732
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and pathological characteristics of patients with glomerular hematuria as the major manifestation].
Wan X; Zhang YM; Liu W; Huang HH; Li JG
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1561-3. PubMed ID: 17959537
[TBL] [Abstract][Full Text] [Related]
20. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.
Coppo R; Peruzzi L; Amore A; Piccoli A; Cochat P; Stone R; Kirschstein M; Linné T
J Am Soc Nephrol; 2007 Jun; 18(6):1880-8. PubMed ID: 17513327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
